Inmune Bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boca Raton, FL
INMB chart
What traders are saying about $INMB
Latest postsInmune Bio, Inc. news
- Quantum Computing Reports $9.5 Million Q3 Revenue and $15.1 Million Net Loss
TradingView ·
- Weekly Recap: 2027 filings, cash risk and XPro partner, INKmune halt
TradingView ·
- INmune Bio Inc. (INMB) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Inmune Stock Price Forecast. Should You Buy INMB?
StockInvest.us ·
- INmune Bio (INMB) Q3 2026 Earnings Call Transcript
fool.com ·
- INmune Bio, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- INmune Bio Inc (INMB) Q3 2026 Earnings Call Highlights: UK Approval Path for Ebstracell Narrows ...
Yahoo Finance ·
- INmune Bio Narrows Its Loss, But Another Ebstrocel Timeline Slip And Rising Dilution Define The Quarter
Finviz ·
- INMB: Ebstrocel advances toward 2027 filings as Q3 loss narrows and cash runway extends through Q3 2027
TradingView ·
- INmune Bio, Inc. (INMB) Misses Q3 EPS by 3c
StreetInsider ·
- $INMB Q3 '26 Earnings Results & Recap
Stocktwits ·
- INmune Bio Q3 2026 Earnings Call Transcript
Benzinga ·
Inmune Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $50,000 | $14,000 | $155,000 | $374,000 |
| Net income | -$46.0M | -$42.0M | -$30.0M | -$27.3M |
| Diluted EPS | $-1.86 | $-2.11 | $-1.67 | $-1.52 |
| Total assets (year end) | $32.4M | $39.6M | $57.0M | $81.8M |
| Cash and equivalents (year end) | $24.8M | $20.9M | $35.8M | $52.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Inmune Bio, Inc.
- Ticker
- INMB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boca Raton, FL
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1711754
Frequently asked questions
What exchange is Inmune Bio, Inc. listed on?
Inmune Bio, Inc. trades on the Nasdaq under the ticker symbol INMB.
What industry is Inmune Bio, Inc. in?
Inmune Bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Inmune Bio, Inc. headquartered?
Inmune Bio, Inc.'s business address on file with the SEC is in Boca Raton, FL.
When does Inmune Bio, Inc.'s fiscal year end?
Inmune Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Inmune Bio, Inc. report?
Inmune Bio, Inc. reported $50,000 in revenue for calendar year 2025, according to its SEC filings.